Business Description
CH Biotech R&D Co Ltd
ISIN : TW0006534001
Compare
Compare
Traded in other countries / regions
6534.Taiwan Index Membership
TSEC Weighted Index IPO Date
2015-07-02Description
CH Biotech R&D Co Ltd is a Taiwan-based company engaged in the manufacture and sales of fertilizer, as well as providing biotechnology services. It is engaged in the research, development, manufacturing, and sales of proprietary plant growth regulators and specialty micronutrient fertilizers. It offers NutriSync 3D plant growers in the form of boron and molybdenum, NutriSync D liquid formulation for dicot crops, CHB-HS for reducing carbon emissions in crop production, CHB-BB2, fruit quality enhancers, and other related products. The company has one reportable segment, Agricultural Biotechnology. Geographically, it derives maximum revenue from the United States, and the rest from other countries.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.6 | |||||
Equity-to-Asset | 0.75 | |||||
Debt-to-Equity | 0.25 | |||||
Debt-to-EBITDA | 0.83 | |||||
Interest Coverage | 37.39 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 7.45 | |||||
Beneish M-Score | -1.99 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.8 | |||||
3-Year EBITDA Growth Rate | 2 | |||||
3-Year EPS without NRI Growth Rate | -0.9 | |||||
3-Year FCF Growth Rate | -8.7 | |||||
3-Year Book Growth Rate | 7.4 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 41.08 | |||||
9-Day RSI | 42.26 | |||||
14-Day RSI | 43.36 | |||||
3-1 Month Momentum % | 0.55 | |||||
6-1 Month Momentum % | 2.12 | |||||
12-1 Month Momentum % | 18.06 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.21 | |||||
Quick Ratio | 1.01 | |||||
Cash Ratio | 0.55 | |||||
Days Inventory | 131.18 | |||||
Days Sales Outstanding | 64.08 | |||||
Days Payable | 11.61 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 5.33 | |||||
Dividend Payout Ratio | 0.9 | |||||
3-Year Dividend Growth Rate | 46.5 | |||||
Forward Dividend Yield % | 5.33 | |||||
5-Year Yield-on-Cost % | 44.98 | |||||
3-Year Average Share Buyback Ratio | -1.3 | |||||
Shareholder Yield % | 5.16 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 83.93 | |||||
Operating Margin % | 34.87 | |||||
Net Margin % | 25.51 | |||||
EBITDA Margin % | 43.97 | |||||
FCF Margin % | 25.37 | |||||
OCF Margin % | 32.38 | |||||
ROE % | 17.43 | |||||
ROA % | 12.32 | |||||
ROIC % | 15.75 | |||||
3-Year ROIIC % | 17.7 | |||||
ROC (Joel Greenblatt) % | 20.32 | |||||
ROCE % | 20.1 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 20.07 | |||||
PE Ratio without NRI | 19.67 | |||||
Shiller PE Ratio | 23.68 | |||||
Price-to-Owner-Earnings | 28.24 | |||||
PEG Ratio | 0.87 | |||||
PS Ratio | 5.11 | |||||
PB Ratio | 3.38 | |||||
Price-to-Tangible-Book | 3.39 | |||||
Price-to-Free-Cash-Flow | 19.87 | |||||
Price-to-Operating-Cash-Flow | 15.62 | |||||
EV-to-EBIT | 15.96 | |||||
EV-to-EBITDA | 11.69 | |||||
EV-to-Revenue | 5.14 | |||||
EV-to-FCF | 20.26 | |||||
Price-to-GF-Value | 0.9 | |||||
Price-to-Projected-FCF | 2.06 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.87 | |||||
Price-to-Graham-Number | 1.72 | |||||
Earnings Yield (Greenblatt) % | 6.27 | |||||
FCF Yield % | 5.08 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
CH Biotech R&D Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 1,819.183 | ||
| EPS (TTM) (NT$) | 4.49 | ||
| Beta | -0.0242 | ||
| 3-Year Sharpe Ratio | 0.16 | ||
| 3-Year Sortino Ratio | 0.27 | ||
| Volatility % | 43.54 | ||
| 14-Day RSI | 43.36 | ||
| 14-Day ATR (NT$) | 1.980944 | ||
| 20-Day SMA (NT$) | 90.63 | ||
| 12-1 Month Momentum % | 18.06 | ||
| 52-Week Range (NT$) | 76.6 - 123.5 | ||
| Shares Outstanding (Mil) | 100.8 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
CH Biotech R&D Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
CH Biotech R&D Co Ltd Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| TWD 4.300000 Cash Dividend | 2026-03-26 | 93.40 (+0.11%) | ||
| TWD 0.500000 Cash Dividend | 2025-08-21 | 106.50 (+2.90%) | ||
| TWD 3.600000 Cash Dividend | 2025-03-20 | 83.30 (-1.77%) | ||
| TWD 0.500000 Cash Dividend | 2024-08-23 | 77.40 (-0.90%) | ||
| 1.15:1 Stock Split | 2022-07-26 | 70.87 (+0.00%) | ||
| 1.05:1 Stock Split | 2020-07-23 | 40.58 (+0.00%) | ||
| 1.34:1 Stock Split | 2019-07-02 | 89.00 (+0.71%) | ||
| 1.12177:1 Stock Split | 2018-07-18 | 82.86 (+0.00%) | ||
| 1.698:1 Stock Split | 2017-09-19 | 90.21 (+0.00%) |
Show
Entries
CH Biotech R&D Co Ltd Frequently Asked Questions
What is CH Biotech R&D Co Ltd(TPE:6534)'s stock price today?
The current price of TPE:6534 is NT$90.10. The 52 week high of TPE:6534 is NT$123.50 and 52 week low is NT$76.60.
When is next earnings date of CH Biotech R&D Co Ltd(TPE:6534)?
The next earnings date of CH Biotech R&D Co Ltd(TPE:6534) is .
Does CH Biotech R&D Co Ltd(TPE:6534) pay dividends? If so, how much?
The Dividend Yield %  of CH Biotech R&D Co Ltd(TPE:6534) is 5.33% (As of Today), Highest Dividend Payout Ratio of CH Biotech R&D Co Ltd(TPE:6534) was 1.03. The lowest was 0.14. And the median was 0.64. The  Forward Dividend Yield % of CH Biotech R&D Co Ltd(TPE:6534) is 5.33%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on CH Biotech R&D Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers